AKT1 and hepatocellular carcinoma: Oroxin B, a flavonoid from Oroxylum indicum (L.)Vent, demonstrated anti-HCC activity and improved HCC pathology by reducing miR-221 levels and deactivating the PTEN/PI3K/Akt pathway (Li et al., 2019).